PROM1 and liver cancer: Moreover, when combined with 3-MA, CD133 aptamer-DOX conjugates achieved a further increase in apoptosis in the liver cancer sphere-forming cells by at least ~140% and ~300% compared with that by free DOX alone or CD133 aptamer-DOX alone, respectively (Supplementary Figure S12).